Clinical Trials Directory

Trials / Completed

CompletedNCT00885274

A Randomized Controlled Trial Comparing Two Timing Regimens of Pico-salax for Colon Cleansing Prior to Colonoscopy

A Randomized Controlled Trial Comparing Two Timing Regimens of Pico-salax for Colon Cleansing Prior to Colonoscopy.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
250 (actual)
Sponsor
Queen's University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Pico-Salax is an osmotic and stimulant bowel cleansing agent used prior to colonoscopy. It is unknown whether splitting the doses (i.e. taking the second dose the morning of the colonoscopy) results in a better bowel cleansing, as research with other agents suggests this may be the case. This study aims to assess whether splitting the dose of Pico-Salax results in a better bowel cleansing than traditional dosing.

Conditions

Interventions

TypeNameDescription
DRUGPico-SalaxBoth doses of Pico-Salax taken the evening prior to colonoscopy
DRUGSplit Dose Pico-SalaxOne dose of Pico-Salax taken the evening prior to colonoscopy and the other the morning of the procedure.

Timeline

Start date
2008-11-01
Primary completion
2011-03-01
Completion
2011-08-01
First posted
2009-04-21
Last updated
2015-08-31

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00885274. Inclusion in this directory is not an endorsement.

A Randomized Controlled Trial Comparing Two Timing Regimens of Pico-salax for Colon Cleansing Prior to Colonoscopy (NCT00885274) · Clinical Trials Directory